The Board of Directors of NATCO Pharma Limited, which met at Hyderabad today, had taken on record the working results for the quarter / half year ended on 30^th September, 2006.    The following are the highlights of the results :

Half year ended on 30^th September, 2006 :

For the half year ended on 30^th September, 2006, as compared to the half year ended on 30^th September, 2005, the revenues have gone up by 32% (from Rs. 100 Crores in financial year 2005-2006 to Rs. 132 Crores –  consolidated – for the financial year 2006-2007). The main drivers for revenues were the US retail business and the oncology formulations in the domestic market.

The profits, after tax, have gone up by 28% - from Rs. 1399 lakhs in the first half of the financial year 2005-2006 to Rs. 2081 lakhs during the corresponding period in the current financial year.  

Quarter ended on 30^th September, 2006 :

Revenues for the second quarter in the current year have gone up by 24% as compared to the last year (from Rs. 54 Crores to Rs. 63 Crores – consolidated). The post tax profit for the second quarter in the current year stood at Rs. 976 lakhs, as compared to Rs. 838 lakhs last year, recording an increase of 17%.

Contd on page 2...